Home › Companies › Protalix Biotherapeutics, Inc. › 2025-2026
At Protalix Biotherapeutics, Inc.'s shareholder meeting held June 25, 2026, in the 2025-2026 proxy season, 92 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 831 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of the Company's named executive… — Protalix Biotherapeutics, Inc.'s filing reports the proposal as approved, with 81% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Protalix Biotherapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 25, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Protalix Biotherapeutics, Inc.’s Form 8-K, filed June 25, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 25, 2026: 11 items on Protalix Biotherapeutics, Inc.’s Form 8-K, filed June 25, 2026: 3 approved · 8 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2025-2026
Explore Protalix Biotherapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Protalix Biotherapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 25, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Eliot Richard Forster, Ph.D. | 32,871,013 | -- | -- | 2,379,140 | 10,705,177 | 93% | Not verified | — |
| Elect Director: Dror Bashan | 32,023,297 | -- | -- | 3,085,555 | 10,705,177 | 91% | Not verified | — |
| Elect Director: Amos Bar Shalev | 28,788,428 | -- | -- | 6,461,724 | 10,705,177 | 82% | Not verified | — |
| Elect Director: Shmuel "Muli" Ben Zvi, Ph.D. | 31,573,749 | -- | -- | 3,676,403 | 10,705,177 | 90% | Not verified | — |
| Elect Director: Pol F. Boudes, M.D. | 32,649,206 | -- | -- | 2,600,947 | 10,705,177 | 93% | Not verified | — |
| Elect Director: Christian Elze | 32,639,041 | -- | -- | 2,611,111 | 10,705,177 | 93% | Not verified | — |
| Elect Director: Gwen A. Melincoff | 32,784,702 | -- | -- | 2,465,451 | 10,705,177 | 93% | Not verified | — |
| Elect Director: Aharon Schwartz, Ph.D. | 30,334,262 | -- | -- | 4,915,890 | 10,705,177 | 86% | Not verified | — |
| 2. Approval, on a non-binding, advisory basis, the compensation of the Company's named executive officers | 28,368,614 | 6,683,937 | 197,602 | -- | 10,705,177 | 81% | Approved | — |
| 3. Approval of the Plan to increase the number of shares of common stock available under the Plan from 17,475,171 shares to 20,975,171 shares and to amend certain other terms of the Plan | 28,161,656 | 6,974,902 | 113,594 | -- | 10,705,177 | 80% | Approved | — |
| 4. Ratification of the appointment of Kesselman & Kesselman, Certified Public Accountant (Isr.), a Member of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the fiscal year ending December 31, 2026 | 42,958,243 | 2,001,734 | 995,352 | -- | -- | 96% | Approved | a majority of the shares present or represented |
Source: Protalix Biotherapeutics, Inc., Form 8-K, filed with the SEC on June 25, 2026 — read the filing on EDGAR.
Each item below shows how the 92 asset managers that disclosed a Protalix Biotherapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: NOMINEES: Aharon Schwartz, Ph.D.
Protalix Biotherapeutics, Inc.’s own tally for this item (“Elect Director: Aharon Schwartz, Ph.D.”): 30,334,262 for, 4,915,890 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 3,135,703 for, 560,066 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 190,987 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 180,000 | Withhold |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 90,188 | Withhold |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 19,290 | Withhold |
| John Hancock | 0 | 0 | 0 | 17,955 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 10,955 | Withhold |
| DWS | 0 | 0 | 0 | 10,693 | Withhold |
| SEI | 10,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 8,955 | Withhold |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: NOMINEES: Amos Bar Shalev
Protalix Biotherapeutics, Inc.’s own tally for this item (“Elect Director: Amos Bar Shalev”): 28,788,428 for, 6,461,724 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 1,390,203 for, 2,305,566 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 1,551,874 | Withhold |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 190,987 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 180,000 | Withhold |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 121,751 | Withhold |
| TIAA | 0 | 0 | 0 | 90,188 | Withhold |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 6,121 | 0 | 0 | 19,020 | Mixed |
| Pacific Life | 0 | 0 | 0 | 23,336 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 19,290 | Withhold |
| John Hancock | 0 | 0 | 0 | 17,955 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 15,878 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 13,641 | Withhold |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 10,955 | Withhold |
| DWS | 0 | 0 | 0 | 10,693 | Withhold |
| SEI | 10,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 8,955 | Withhold |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: NOMINEES: Christian Elze
Protalix Biotherapeutics, Inc.’s own tally for this item (“Elect Director: Christian Elze”): 32,639,041 for, 2,611,111 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 3,695,769 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 190,987 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 180,000 | 0 | 0 | 0 | For |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 90,188 | 0 | 0 | 0 | For |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,290 | 0 | 0 | 0 | For |
| John Hancock | 17,955 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 10,955 | 0 | 0 | 0 | For |
| DWS | 10,693 | 0 | 0 | 0 | For |
| SEI | 10,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,955 | 0 | 0 | 0 | For |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: NOMINEES: Dror Bashan
Protalix Biotherapeutics, Inc.’s own tally for this item (“Elect Director: Dror Bashan”): 32,023,297 for, 3,085,555 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 3,695,769 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 190,987 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 180,000 | 0 | 0 | 0 | For |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 90,188 | 0 | 0 | 0 | For |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,290 | 0 | 0 | 0 | For |
| John Hancock | 17,955 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 10,955 | 0 | 0 | 0 | For |
| DWS | 10,693 | 0 | 0 | 0 | For |
| SEI | 10,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,955 | 0 | 0 | 0 | For |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: NOMINEES: Eliot Richard Forster, Ph.D.
Protalix Biotherapeutics, Inc.’s own tally for this item (“Elect Director: Eliot Richard Forster, Ph.D.”): 32,871,013 for, 2,379,140 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 3,598,462 for, 97,307 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 190,987 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 180,000 | 0 | 0 | 0 | For |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 90,188 | Withhold |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,290 | 0 | 0 | 0 | For |
| John Hancock | 17,955 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 10,955 | 0 | 0 | 0 | For |
| DWS | 10,693 | 0 | 0 | 0 | For |
| SEI | 10,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,955 | 0 | 0 | 0 | For |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: NOMINEES: Gwen A. Melincoff
Protalix Biotherapeutics, Inc.’s own tally for this item (“Elect Director: Gwen A. Melincoff”): 32,784,702 for, 2,465,451 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 3,695,769 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 190,987 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 180,000 | 0 | 0 | 0 | For |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 90,188 | 0 | 0 | 0 | For |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,290 | 0 | 0 | 0 | For |
| John Hancock | 17,955 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 10,955 | 0 | 0 | 0 | For |
| DWS | 10,693 | 0 | 0 | 0 | For |
| SEI | 10,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,955 | 0 | 0 | 0 | For |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: NOMINEES: Pol F. Boudes, M.D.
Protalix Biotherapeutics, Inc.’s own tally for this item (“Elect Director: Pol F. Boudes, M.D.”): 32,649,206 for, 2,600,947 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 3,695,769 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 190,987 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 180,000 | 0 | 0 | 0 | For |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 90,188 | 0 | 0 | 0 | For |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,290 | 0 | 0 | 0 | For |
| John Hancock | 17,955 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 10,955 | 0 | 0 | 0 | For |
| DWS | 10,693 | 0 | 0 | 0 | For |
| SEI | 10,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,955 | 0 | 0 | 0 | For |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: NOMINEES: Shmuel "Muli" Ben Zvi, Ph.D.
Protalix Biotherapeutics, Inc.’s own tally for this item (“Elect Director: Shmuel "Muli" Ben Zvi, Ph.D.”): 31,573,749 for, 3,676,403 withheld, per its Form 8-K filed June 25, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 3,225,891 for, 469,878 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 190,987 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 180,000 | Withhold |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 90,188 | 0 | 0 | 0 | For |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 19,290 | Withhold |
| John Hancock | 0 | 0 | 0 | 17,955 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 10,955 | Withhold |
| DWS | 0 | 0 | 0 | 10,693 | Withhold |
| SEI | 10,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 8,955 | Withhold |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
80% Approved · of votes cast
Description as filed by funds: To approve the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan (the "Plan"), in order to increase the number of shares of common stock available under the Plan from 17,475,171 shares to 20,975,171 shares and to amend certain other terms of the Plan;
Protalix Biotherapeutics, Inc.’s own tally for this item (“3. Approval of the Plan to increase the number of shares of common stock available under the Plan from 17,475,171 shares to 20,975,171 shares and to amend certain other terms of the Plan”): 28,161,656 for, 6,974,902 against — passed, per its Form 8-K filed June 25, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(3) approved an Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan (the "Plan"), to increase the number of shares of common stock available under the Plan from 17,475,171 shares to 20,975,171 shares and to amend certain other terms of the Plan; and”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 3,705,869 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 190,987 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 180,000 | 0 | 0 | 0 | For |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 90,188 | 0 | 0 | 0 | For |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,290 | 0 | 0 | 0 | For |
| John Hancock | 17,955 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 10,955 | 0 | 0 | 0 | For |
| DWS | 10,693 | 0 | 0 | 0 | For |
| SEI | 10,200 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 10,100 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
81% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement that accompanies this notice;
Protalix Biotherapeutics, Inc.’s own tally for this item (“2. Approval, on a non-binding, advisory basis, the compensation of the Company's named executive officers”): 28,368,614 for, 6,683,937 against — passed, per its Form 8-K filed June 25, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 0 | 190,987 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 180,000 | 0 | 0 | Against |
| Charles Schwab | 0 | 159,311 | 0 | 0 | Against |
| Equitable | 115,891 | 5,860 | 0 | 0 | For |
| TIAA | 90,188 | 0 | 0 | 0 | For |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 0 | 31,470 | 0 | 0 | Against |
| Nationwide | 19,020 | 6,121 | 0 | 0 | Mixed |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 19,290 | 0 | 0 | Against |
| John Hancock | 0 | 17,955 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 0 | 10,955 | 0 | 0 | Against |
| DWS | 0 | 10,693 | 0 | 0 | Against |
| SEI | 0 | 10,200 | 0 | 0 | Against |
| T. Rowe Price | 0 | 8,955 | 0 | 0 | Against |
| Northern Trust | 8,357 | 0 | 0 | 0 | For |
Fund voting reports, all 35 managers: 3,007,153 for, 688,616 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MAK CAPITAL ONE LLC | 776,521 | 0 | 0 | 0 | For |
| Northern Trust | 730,659 | 2,808 | 0 | 0 | For |
| BlackRock | 618,435 | 443 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 598,274 | 0 | 0 | 0 | For |
| State Street | 507,419 | 6,721 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 194,472 | 0 | 0 | 0 | For |
| Round Rock Advisors LLC | 0 | 191,001 | 0 | 0 | Against |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 189,100 | 0 | 0 | Against |
| EVERGREEN CAPITAL MANAGEMENT LLC | 172,806 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 159,311 | 0 | 0 | Against |
| Renaissance | 0 | 147,212 | 0 | 0 | Against |
| AQR | 0 | 122,966 | 0 | 0 | Against |
| T. Rowe Price | 0 | 104,740 | 0 | 0 | Against |
| Nuveen | 95,190 | 0 | 0 | 0 | For |
| Lazard | 0 | 70,359 | 0 | 0 | Against |
| Vanguard | 63,351 | 0 | 0 | 0 | For |
| Goldman Sachs | 49,942 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 46,552 | 0 | 0 | Against |
| Invesco | 0 | 34,553 | 0 | 0 | Against |
| Dimensional | 0 | 31,536 | 0 | 0 | Against |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 31,100 | 0 | 0 | Against |
| JPMorgan | 29,683 | 0 | 0 | 0 | For |
| State of Alaska, Department of Revenue | 0 | 21,831 | 0 | 0 | Against |
| MetLife Investment Management, LLC | 0 | 18,409 | 0 | 0 | Against |
| John Hancock | 0 | 17,955 | 0 | 0 | Against |
Institutional-manager reports, all 70 managers: 3,884,904 for, 1,346,323 against, 12,000 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Kesselman & Kesselman, Certified Public Accountant (Isr.), a member of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the fiscal year ending December 31, 2026;
Protalix Biotherapeutics, Inc.’s own tally for this item (“4. Ratification of the appointment of Kesselman & Kesselman, Certified Public Accountant (Isr.), a Member of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the fisc”): 42,958,243 for, 2,001,734 against — passed, per its Form 8-K filed June 25, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(4) ratified the appointment of Kesselman & Kesselman, Certified Public Accountant (Isr.), a Member of PricewaterhouseCoopers International Limited, as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the shares present or represented (“majority of the shares present”).
The 36 asset managers below reported 3,705,869 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,551,874 | 0 | 0 | 0 | For |
| Fidelity | 503,923 | 0 | 0 | 0 | For |
| Vanguard | 439,301 | 0 | 0 | 0 | For |
| Dimensional | 190,987 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 180,000 | 0 | 0 | 0 | For |
| Charles Schwab | 159,311 | 0 | 0 | 0 | For |
| Equitable | 121,751 | 0 | 0 | 0 | For |
| TIAA | 90,188 | 0 | 0 | 0 | For |
| WisdomTree | 79,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 42,578 | 0 | 0 | 0 | For |
| GPS Funds I | 33,278 | 0 | 0 | 0 | For |
| Global X | 31,470 | 0 | 0 | 0 | For |
| Nationwide | 25,141 | 0 | 0 | 0 | For |
| Pacific Life | 23,336 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,290 | 0 | 0 | 0 | For |
| John Hancock | 17,955 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 15,878 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,641 | 0 | 0 | 0 | For |
| Voya | 11,494 | 0 | 0 | 0 | For |
| ProShares | 10,955 | 0 | 0 | 0 | For |
| DWS | 10,693 | 0 | 0 | 0 | For |
| SEI | 10,200 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 10,100 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 80,571,642 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 1.93% |
| 2 | Fidelity | 0.63% |
| 3 | Vanguard | 0.55% |
| 4 | Dimensional | 0.24% |
| 5 | BRIDGEWAY FUNDS INC | 0.22% |
| 6 | Charles Schwab | 0.20% |
| 7 | Equitable | 0.15% |
| 8 | TIAA | 0.11% |
| 9 | WisdomTree | 0.10% |
| 10 | Lincoln Financial | 0.06% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | MAK CAPITAL ONE LLC | 0.96% |
| 2 | Northern Trust | 0.91% |
| 3 | BlackRock | 0.77% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.74% |
| 5 | State Street | 0.64% |
| 6 | MELLON INVESTMENTS Corp | 0.24% |
| 7 | Round Rock Advisors LLC | 0.24% |
| 8 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.23% |
| 9 | EVERGREEN CAPITAL MANAGEMENT LLC | 0.21% |
| 10 | Charles Schwab | 0.20% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| HOLD Alapkezelo Zrt. | 5.16% | 13G |
| BlackRock | 4.49% | 13F |
| MAK Capital Fund LP | 4.49% | 13G |
| Dror Bashan | 4.32% | DEF14A |
| Renaissance Technologies | 1.52% | 13F |
| State Street | 1.21% | 13F |
| Northern Trust | 1.10% | 13F |
| Geode Capital | 1.07% | 13F |
| Yaron Naos | 1.00% | DEF14A |
| Vanguard Group | 0.61% | 13F |
Percentages above are of 80,571,642 shares outstanding, as reported by Protalix Biotherapeutics, Inc. on its Form 10-Q dated May 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Protalix Biotherapeutics, Inc.’s 10-Q dated May 1, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Protalix Biotherapeutics, Inc. proxy season coverage: 2023-2024 · 2025-2026 (this page).
proxyvotesnow.com, “Protalix Biotherapeutics (PLX) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/protalix-biotherapeutics-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.